Dual anti-platelet therapy with aspirin and clopidogrel might be ineffective in cardiologic patients regarding the flow-cytometric platelet reactivity index

被引：0
|
作者：
Prueller, Florian [1 ]
Ramschak, Heimo [1 ]
Hoedl, Ronald [2 ]
Kainz, Johann [1 ]
Truschnig, Martie [1 ]
机构：
[1] Med Univ Graz, Klin Inst Med & Chem Labor Diagnost, Graz, Austria
[2] Med Univ Graz, Univ Klin Innere Med, Graz, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2008年 / 120卷 / 15-16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A54 / A54
页数：1
相关论文
共 50 条
  • [41] HDL-Cholesterol serves as a powerful predictor of platelet activation in patients with coronary heart disease on dual anti-platelet therapy
    Jaeger, B.
    Andric, T.
    Piackova, E.
    Wojta, J.
    Huber, K.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S302 - S302
  • [42] DO WE NEED SYSTEMIC ANTICOAGULATION AND DUAL ANTI-PLATELET THERAPY FOR FRACTIONAL FLOW RESERVE CALCULATION?
    Dhindsa, Mandeep
    Boccalandro, Fernando
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1943 - A1943
  • [43] Outcomes of Ischemic Stroke amongst patients on Long-term Current Use of Dual Anti-platelet Therapy Versus Aspirin Monotherapy.
    Patel, Urvish
    Shah, Dhaivat
    Malik, Preeti
    Patel, Khush
    Lunagariya, Abhishek
    NEUROLOGY, 2020, 94 (15)
  • [44] Impact of concomitant use of proton pump inhibitors on anti-platelet therapy of clopidogrel in patients undergoing percutaneous coronary intervention
    何鹏程
    蒋磊
    马雪芬
    谭宁
    周颖玲
    陈纪言
    South China Journal of Cardiology, 2013, 14 (04) : 219 - 223
  • [45] Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease
    Guthikonda, Sasidhar
    Alviar, Carlos L.
    Vaduganathan, Muthiah
    Arikan, Mehmet
    Tellez, Armando
    DeLao, Timothy
    Granada, Juan F.
    Dong, Jing-Fei
    Kleiman, Neal S.
    Lev, Eli I.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (09) : 743 - 749
  • [46] Impact of Dual Anti-platelet Therapy in Coronary Artery Bypass Graft Patients on Graft Outcomes and Mortality
    Ch, Iftikhar A.
    Tahirkheli, Naeem
    Wu, Pei-Tzu
    Qadar, Abdul
    Usmani, Ahmad
    Ullah, Raja
    Weitzel, Hunter
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [47] Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy
    Grodzinsky, Anna
    Arnold, Suzanne V.
    Wang, Tracy Y.
    Sharma, Praneet
    Gosch, Kensey
    Jones, Philip G.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    McGuire, Darren K.
    Cohen, David J.
    Spertus, John A.
    Chhatriwalla, Adnan K.
    Lind, Marcus
    Graham, Garth
    Kosiborod, Mikhail
    AMERICAN HEART JOURNAL, 2016, 182 : 111 - 118
  • [48] Urinary 11-dehydro-thromboxane B2 as a marker of the anti-platelet effects of clopidogrel or aspirin therapy in healthy male volunteers
    Armstrong, P. C. J.
    Dhanji, A. A.
    Tucker, A. T.
    Mitchell, J. A.
    Warner, T. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 573 - 573
  • [49] URINARY 11-DEHYDRO-THROMBOXANE B2 AS A MARKER OF THE ANTI-PLATELET EFFECTS OF CLOPIDOGREL OR ASPIRIN THERAPY IN HEALTHY MALE VOLUNTEERS
    Armstrong, P. C. J.
    Dhanji, A. A.
    Tucker, A. T.
    Mitchell, J. A.
    Warner, T. D.
    HEART, 2009, 95 (22)
  • [50] Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor
    Verdoia, M.
    Barbieri, L.
    Schaffer, A.
    Nardin, M.
    Marino, P.
    Suryapranata, H.
    De Luca, G.
    EUROPEAN HEART JOURNAL, 2015, 36 : 351 - 351
12345